291 related articles for article (PubMed ID: 25842913)
21. Rational polytherapy with lacosamide in clinical practice: results of a Spanish cohort analysis RELACOVA.
Villanueva V; López-Gomáriz E; López-Trigo J; Palau J; García M; Villarroya T; Bonet M; Santafé C
Epilepsy Behav; 2012 Mar; 23(3):298-304. PubMed ID: 22370116
[TBL] [Abstract][Full Text] [Related]
22. Oxcarbazepine add-on for drug-resistant partial epilepsy.
Castillo S; Schmidt DB; White S
Cochrane Database Syst Rev; 2000; (3):CD002028. PubMed ID: 10908522
[TBL] [Abstract][Full Text] [Related]
23. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
[TBL] [Abstract][Full Text] [Related]
25. [Russian experience of lacosamide (vimpat) usage in treatment of uncontrolled focal epilepsy].
Lebedeva AV; Burd SG; Belyaev OV; Vlasov PN; Dorofeeva MY; Ismailov AM; Kissin MY; Kovaleva IY; Koroleva NY; Lipatova LV; Mukhin KY; Solomatin YV; Chervyakov AV; Shikhkerimov RG; Pylaeva OA; Freidkova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):74-81. PubMed ID: 28005051
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
27. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
28. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
[TBL] [Abstract][Full Text] [Related]
29. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures.
García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A
Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484
[TBL] [Abstract][Full Text] [Related]
30. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice.
Pauletto G; Bergonzi P;
Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial.
Zadeh WW; Escartin A; Byrnes W; Tennigkeit F; Borghs S; Li T; Dedeken P; De Backer M;
Seizure; 2015 Sep; 31():72-9. PubMed ID: 26362380
[TBL] [Abstract][Full Text] [Related]
32. [Effect of lacosamide on the quality of life of patients with epilepsy].
García-Escrivá A; López-Hernández N; Llorca V; Alfaro A; Asensio-Asensio M; García C; Lezcano-Rodas M; Medrano V; Palao S
Rev Neurol; 2014 Aug; 59(4):145-52. PubMed ID: 25059264
[TBL] [Abstract][Full Text] [Related]
33. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
[TBL] [Abstract][Full Text] [Related]
34. [Clinical experience with lacosamide in Galicia: the GALACO study].
Rodriguez-Osorio X; Lopez-Gonzalez FJ; Pato-Pato A; Cebrian-Perez E; Marey-Lopez J; Corredera-Garcia E; Rubio-Nazabal E; Castro-Vilanova MD; Abella-Corral J; Rodriguez-Regal A; Amigo-Jorrin MC; Pego-Reigosa R;
Rev Neurol; 2015 Dec; 61(12):536-42. PubMed ID: 26662871
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of the efficacy and influencing factors of sodium channel blockers in the treatment of focal epilepsy in infants under 6 months of age].
Ma YP; Deng J; Fu ZR; Chen CH; Wang XH; Wang X; Weng JW; Shen YH
Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):983-988. PubMed ID: 37899337
[No Abstract] [Full Text] [Related]
36. Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients.
Böttcher S; Lutz MT; Mayer T
Epilepsia; 2017 Oct; 58(10):1749-1754. PubMed ID: 28804872
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.
Zou XM; Chen JN; An DM; Hao NY; Hong Z; Hao XT; Rao P; Zhou D
Seizure; 2015 Jul; 29():81-5. PubMed ID: 26076847
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacoeconomic aspects of monotherapy of focal epilepsy].
Mkrtchyan VR; Kaimovsky IL
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11. Vyp. 2):92-98. PubMed ID: 32207738
[TBL] [Abstract][Full Text] [Related]
40. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
